Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05435703
Other study ID # R20023
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 7, 2020
Est. completion date December 30, 2021

Study information

Verified date January 2023
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

During routine subtyping of confirmed primary aldosteronism by adrenal vein sampling extra plasma samples are drawn from both renal veins and from inferior vena cava. Plasma renin concentration and renin activity are analysed from these samples. Adrenal computed tomographies are analysed for cysts and other possible pathology by a blinded radiologist. Aim is to evaluate correlation between renal pathology and renin measurements.


Description:

Aim of the study is to evaluate the prevalence of renal cysts and their association with renin concentrationand acitivity in samples from renal veins and inferior vena cava (IVC) in patients who undergo an adrenal vein sampling (AVS) because of primary aldosteronism. In a prospective study up to 200 patients who have been referred to Tampere University Hospital for AVS are recruited during 24 months. Informed consent is taken. Clinical, medication, radiological and laboratory information according to Endcrine Society guidelines is collected. Interventional radiologist will draw venous blood from both renal veins and from IVC for later renin analyses. One, blinded radiologist will record renal pathology of cysts but also other abnormal radiologic features. An interim analysis will be done when 60-100 patients have been recruited or at 6-12 months from the start of the study. Study will be stopped if significant difference can be found in renin measurement in patients with renal cysts compared with patients without renal cysts.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date December 30, 2021
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Confirmed primary aldosteronism according to Endocrine Society guidelines - Adrenal vein sampling performed in Tampere University Hospital - Informed consent Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (4)

Lead Sponsor Collaborator
Tampere University Hospital Helsinki University Central Hospital, Kuopio University Hospital, Tampere University

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Association of any renal cyst finding to graded baseline renin concentration (mU/L) Number of patients with renal cysts when renin concentration (mU/L) is low, low normal or high normal to high Baseline
Secondary Correlation of renin concentration (mU/L) in inferior vena cava in all patients and in patients with or without renal cysts (or other renal pathology) Renin concentration difference (mU/L) During procedure
Secondary Correlation of renin activity (ng of Ang I/ml/h) in inferior vena cava in all patients and in patients with or without renal cysts (or other renal pathology) Renin activity difference (ng of Ang I/ml/h) During procedure
Secondary Correlation of renin concentration (mU/l) in right and left renal vein from the side with or without renal cysts (or other renal pathology) Concentration difference (mU/l) During procedure
Secondary Correlation of renin activity (ng of Ang I/ml/h) in right and left renal vein from the side with or without renal cysts (or other renal pathology) Activity difference (ng of Ang I/ml/h) During procedure
Secondary Prevalence (%) of renal cysts in patients in computed tomography with contrast media Prevalence of cysts Baseline
Secondary Association of prevalence of renal cysts (%) with severity of hypertension Percentage of patients with renal cysts when patients are grouped according to quartiles of severity of hypertension Baseline
Secondary Association of prevalence of renal cysts (%) with duration (years) of hypertension Percentage of patients with renal cysts when patients are grouped according to quartiles of duration of hypertension (years) Baseline
Secondary Association of prevalence of renal cysts (%) with plasma potassium concentration (mmol/l) Percentage of patients with renal cysts (%) when patients are grouped according to quartiles of lowest plasma potassium Baseline
Secondary Association of prevalence of renal cysts (%) with severity of primary aldosteronism Percentage of patients with renal cysts when patients are grouped according to quartiles of aldosterone to renin ratio (pmol/L)/(mU/L) Baseline
Secondary Renin concentration (mU/l) in renal veins on the side of renal cysts compared with the side with no cysts of each kidney Concentration difference During procedure
Secondary Renin concentration (mU/l) in inferior vena cava in patients with renal cysts compared with patients with no cysts Concentration difference During procedure
Secondary Renin activity (ng of Ang I/ml/h) in renal veins on the side of renal cysts compared with the side with no cysts Activity difference During procedure
Secondary Renin activity (ng of Ang I/ml/h) in inferior vena cava in patients with renal cysts Activity difference During procedure
Secondary Association of renal cyst finding to baseline renin concentration (mU/l) in different age groups Number of patients with renal cysts when renin concentration is low, low normal or high normal to high Baseline
See also
  Status Clinical Trial Phase
Completed NCT02885662 - Study of CS-3150 in Patients With Primary Aldosteronism N/A
Withdrawn NCT02096939 - Microvascular Function in Primary Aldosteronism N/A
Completed NCT01728493 - Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment N/A
Recruiting NCT06228677 - Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
Recruiting NCT06047912 - Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
Recruiting NCT04991961 - Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Screening for Primary Aldosteronism
Recruiting NCT05501080 - The Effect of SAAE on Ventricular Remodeling in PA Patients N/A
Recruiting NCT05405101 - Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA N/A
Recruiting NCT05973604 - Prevalence of Primary Aldosteronism in Atrial Fibrillation
Recruiting NCT05826080 - Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism
Completed NCT04179019 - Calcium Channel Blockade in Primary Aldosteronism Phase 2
Completed NCT03500120 - Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism
Recruiting NCT04213963 - Prospective Study on Primary Aldosteronism in Resistant Hypertension
Recruiting NCT02945904 - IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism
Enrolling by invitation NCT02257450 - Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study N/A
Recruiting NCT05561361 - The Effect of SAAE on Vascular Endothelial Function in PA Patients
Completed NCT03398785 - Adrenal Artery Ablation Treats Primary Aldosteronism Phase 3
Recruiting NCT03224312 - Chongqing Primary Aldosteronism Study
Recruiting NCT04428827 - Outcome of Patients With Primary Aldosteronism
Completed NCT02756754 - Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism N/A